Genetic information in the diagnosis and treatment of hypertension
- 60 Downloads
Advancement in cardiovascular science should be measured by a number of new diagnostic and therapeutic options applied in clinical practice as a result of translational research. Hypertension genetics is a good example of such a successful transfer of knowledge from bench to bedside. There are genetic methods currently used as diagnostic tools in patients presenting with secondary forms of hypertension, including primary hyperaldosteronism, Cushing’s syndrome, pheochromocytoma, and chronic kidney disease. Directed treatment that corrects pathophysiologic abnormalities is available for several monogenic forms of hypertension as a result of uncovering their underlying genetic mechanisms. Progress in hypertension pharmacogenetics and pharmacogenomics brings closer a perspective of personalized antihypertensive treatment and gene transfer strategies, which, although still considered as innovative approaches, may soon become options to treat, control, and, possibly, cure hypertension.
KeywordsAntihypertensive Treatment Multiple Endocrine Neoplasia Type Polycystic Kidney Disease Primary Aldosteronism Blood Pressure Response
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 10.Groussin L, Horvath A, Jullian E, et al.: A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J Clin Endocrinol Metab 2006, 91:1943–1949. An excellent example of progress in cardiovascular genetics in uncovering mechanisms of endocrine diseases.PubMedCrossRefGoogle Scholar
- 15.Wiesner GL, Snow-Bailey K: Multiple endocrine neoplasia type 2. http://220.127.116.11/servlet/access?db=geneclinic s&site=gt&id=8888891&key=fkWDBgv-gytUT&gry=& fcn=y&fw=p6V2&.lename=/profiles/men2/index.html. Accessed June 15, 2006. The most up-to-date information on genetic testing in patients with MEN2.Google Scholar
- 18.Schimke RN, Collins DL, Stolle CA: Von Hippel-Lindau syndrome. http://18.104.22.168/servlet/access?db=genec linics&site=gt&id=8888892&key=rcP7MCsyeptb1&gry =&fcn=y&fw=HfTO&.lename=/profiles/vhl/index.html. Accessed June 15, 2006. The most up-to-date information on genetic testing in patients with von Hippel-Lindau syndrome.Google Scholar
- 24.Friedman JM. Neurofibromatosis 1. http://22.214.171.124/ servlet/access?db=geneclinics&site=gt&id=8888892&key =3t6-IckLoIkR3&gry=&fcn=y&fw=lXJ7&filename=/profiles/nf1/index.html. Accessed June 15, 2006.Google Scholar
- 36.Perrone RD, Miskulin DC:. Hypertension in individuals at risk for autosomal dominant polycystic kidney disease: to screen or not to screen. Am J Kidney Dis 2005, 46:557–559. An excellent editorial containing critical evaluation of indications for genetic screening in ADPKD.PubMedCrossRefGoogle Scholar
- 53.Padmanabhan S, Wallace C, Munroe PB, et al.: Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study. Hypertension 2006, 47:603–608. One of the first examples of a successful pharmacogenomic approach in studies on hypertension.PubMedCrossRefGoogle Scholar